Search

everythinglearnresearchcommunity

for

Search:↓

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Targeting the narrowest part of the anterior chamber angle may help prevent pupil block in glaucoma.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

CTP-543 is generally safe for treating alopecia areata.

Ion sequential therapy improves heart function after a heart attack.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Fractional infrared technology is effective and safe for treating cervical laxity.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Using PBMT and Respiro Mirtol forte after septoplasty reduces pain and inflammation.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Transcranial electrical stimulation with bisphosphonates helps maintain bone collagen better than bisphosphonates alone.